Assessment of High-Sensitivity C-Reactive Protein Levels as Diagnostic Discriminator of Maturity-Onset Diabetes of the Young Due to HNF1A Mutations

Evaluation of Serum 1,5 Anhydroglucitol Levels as a Clinical Test to Differentiate Subtypes of Diabetes

(2009) A. Pal et al.   DIABETES CARE

A genetic diagnosis ofHNF1Adiabetes alters treatment and improves glycaemic control in the majority of insulin-treated patients

(2009) M. Shepherd et al.   DIABETIC MEDICINE

Association of C-reactive protein with type 2 diabetes: prospective analysis and meta-analysis

(2009) C. C. Lee et al.   DIABETOLOGIA

Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia

(2009) Kara K. Osbak et al.   HUMAN MUTATION

An investigation of serum concentration of apoM as a potential MODY3 marker using a novel ELISA

(2009) C. Cervin et al.   JOURNAL OF INTERNAL MEDICINE

An assessment of the joint associations of aspirin and statin use with C-reactive protein concentration

(2008) Matt Fisher et al.   AMERICAN HEART JOURNAL

Polymorphisms of the HNF1A Gene Encoding Hepatocyte Nuclear Factor-1α are Associated with C-Reactive Protein

(2008) Alexander P. Reiner et al.   AMERICAN JOURNAL OF HUMAN GENETICS

Loci Related to Metabolic-Syndrome Pathways Including LEPR,HNF1A, IL6R, and GCKR Associate with Plasma C-Reactive Protein: The Women's Genome Health Study

(2008) Paul M. Ridker et al.   AMERICAN JOURNAL OF HUMAN GENETICS

Clinical Application of 1,5-Anhydroglucitol Measurements in Patients with Hepatocyte Nuclear Factor-1  Maturity-Onset Diabetes of the Young

(2008) J. Skupien et al.   DIABETES CARE

Can complement factors 5 and 8 and transthyretin be used as biomarkers for MODY1 (HNF4A-MODY) and MODY3 (HNF1A-MODY)?

(2008) E. Karlsson et al.   DIABETIC MEDICINE

Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young

(2008) S. Ellard et al.   DIABETOLOGIA